BCL2A1 and Langerhans cell histiocytosis: Similarly to IL-17A expression [Figure 2B and (8)], BCL2A1 expression in Mo-DCs from LCH patients was correlated neither with the disease activity class nor with any chemotherapeutic treatment (Table 1).